
Sign up to save your podcasts
Or
Ozempic. Wegovy. Mounjaro. Zepbound. You’ve probably heard the name of one of these drugs in the past few years—maybe you’ve even thought about taking them. Every day, more Americans are taking these drugs known as GLP-1s, either for chronic conditions like diabetes or, increasingly, for weight loss. So do these drugs deliver on the promise of easy weight loss? And are they right for everyone? This episode, we talk with Mayo Clinic dietitian and host of Mayo Clinic On Nutrition Tara Schmidt about the drugs that have taken weight loss culture by storm.
Find us online at Mayo Clinic Press for more health and wellness articles, podcasts and books.
Do you have feedback, questions or topic suggestions? Email us at [email protected].
4.9
2626 ratings
Ozempic. Wegovy. Mounjaro. Zepbound. You’ve probably heard the name of one of these drugs in the past few years—maybe you’ve even thought about taking them. Every day, more Americans are taking these drugs known as GLP-1s, either for chronic conditions like diabetes or, increasingly, for weight loss. So do these drugs deliver on the promise of easy weight loss? And are they right for everyone? This episode, we talk with Mayo Clinic dietitian and host of Mayo Clinic On Nutrition Tara Schmidt about the drugs that have taken weight loss culture by storm.
Find us online at Mayo Clinic Press for more health and wellness articles, podcasts and books.
Do you have feedback, questions or topic suggestions? Email us at [email protected].
1,720 Listeners
868 Listeners
1,434 Listeners
290 Listeners
9,289 Listeners
1,223 Listeners
8,214 Listeners
12,624 Listeners
2,074 Listeners
374 Listeners
20,217 Listeners
10,704 Listeners
43 Listeners
38 Listeners
90 Listeners